Reinvestigating the role of igM in rabies virus postexposure vaccination

Journal of Virology

Volumn 87, Issue 16, 2013, Pages 9217-9222

  Dorfmeier, Corin L ^a   Shen, Shixue ^a   Tzvetkov, Evgeni P ^a   McGettigan, James P ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY; RABIES VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; IMMUNE RESPONSE; MOUSE; MUSCLE TISSUE; NEWBORN; NONHUMAN; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; RABIES; RABIES VIRUS; SINGLE DRUG DOSE; SPINAL CORD; SURVIVAL RATE; VIRUS DETECTION; VIRUS LOAD; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE;

ANIMAL STRUCTURES; ANIMALS; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN M; MICE; POST-EXPOSURE PROPHYLAXIS; RABIES; RABIES VACCINES; RABIES VIRUS; SURVIVAL ANALYSIS; VACCINATION; VIRAL LOAD;

EID: 84881258057     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00995-13     Document Type: Article

References (34)

1. Bunschoten H, Dietzschold B, Claassen I, Klapmuts R, Uytdehaag F, Osterhaus A. 1990. Rabies virus cross-reactive murine T cell clones: analysis of helper and delayed-type hypersensitivity function. Viral Immunol. 3:41-53.
2. Baer GM. 2007. The history of rabies, p 11-19. In Jackson AC, Wunner WH (ed), Rabies. Elsevier Science, Irvine, CA.
3. Mifune K, Takeuchi E, Napiorkowski PA, Yamada A, Sakamoto K. 1981. Essential role of T cells in the postexposure prophylaxis of rabies in mice. Microbiol. Immunol. 25:895-904.
4. Perry LL, Lodmell DL. 1991. Role of CD4+ and CD8+ T cells in murine resistance to street rabies virus. J. Virol. 65:3429-3434.
5. Turner GS. 1976. Thymus dependence of rabies vaccine. J. Gen. Virol. 33:535-538.
6. Dorfmeier CL, Lytle AG, Dunkel AL, Gatt A, McGettigan JP. 2012. Protective vaccine-induced CD4+ T cell-independent B cell responses against rabies infection. J. Virol. 86:11533-11540.
7. Turner GS. 1978. Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine. J. Gen. Virol. 40:595-604.
8. Jackson AC. 2011. Update on rabies. Res. Rep. Trop. Med. 2:31-43.
9. Pone EJ, Zan H, Zhang J, Al-Qahtani A, Xu Z, Casali P. 2010. Toll-like receptors and B-cell receptors synergize to induce immunoglobulin classswitch DNA recombination: relevance to microbial antibody responses. Crit. Rev. Immunol. 30:1-29.
10. Racine R, Winslow GM. 2009. IgM in microbial infections: taken for granted? Immunol. Lett. 125:79-85.
11. Diamond MS, Sitati EM, Friend LD, Higgs S, Shrestha B, Engle M. 2003. A critical role for induced IgM in the protection against West Nile virus infection. J. Exp. Med. 198:1853-1862.
12. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J. 2000. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192:271-280.
13. Kopf M, Brombacher F, Bachmann MF. 2002. Role of IgM antibodies versus B cells in influenza virus-specific immunity. Eur. J. Immunol. 32: 2229-2236.
14. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H, Zinkernagel RM. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286:2156-2159.
15. Hangartner L, Zinkernagel RM, Hengartner H. 2006. Antiviral antibody responses: the two extremes of a wide spectrum. Nat. Rev. Immunol. 6:231-243.
16. McGettigan JP. 2010. Experimental rabies vaccines for humans. Expert Rev. Vaccines 9:1177-1186.
17. Cenna J, Hunter M, Tan GS, Papaneri AB, Ribka EP, Schnell MJ, Marx PA, McGettigan JP. 2009. Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates. J. Infect. Dis. 200:1251-1260.
18. Schnell MJ, Foley HD, Siler CA, McGettigan JP, Dietzschold B, Pomerantz RJ. 2000. Recombinant rabies virus as potential live-viral vaccines for HIV-1. Proc. Natl. Acad. Sci. U. S. A. 97:3544-3549.
19. Conzelmann KK, Cox JH, Schneider LG, Thiel HJ. 1990. Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19. Virology 175:485-499.
20. Mebatsion T, Weiland F, Conzelmann KK. 1999. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J. Virol. 73:242-250.
21. Morimoto K, Hooper DC, Carbaugh H, Fu ZF, Koprowski H, Dietzschold B. 1998. Rabies virus quasispecies: implications for pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 95:3152-3156.
22. Cenna J, Tan GS, Papaneri AB, Dietzschold B, Schnell MJ, McGettigan JP. 2008. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene. Vaccine 26:6405-6414.
23. Dorfmeier CL, Tzvetkov EP, Gatt A, McGettigan JP. 2013. Investigating the role for IL-21 in rabies virus vaccine-induced immunity. PLoS Negl. Trop. Dis. 3:e2129. doi:10.1371/journal.pntd.0002129.
24. Boes M, Esau C, Fischer MB, Schmidt T, Carroll M, Chen J. 1998. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 160:4776-4787.
25. Alugupalli KR, Gerstein RM, Chen J, Szomolanyi-Tsuda E, Woodland RT, Leong JM. 2003. The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J. Immunol. 170:3819-3827.
26. Prosniak M, Zborek A, Scott GS, Roy A, Phares TW, Koprowski H, Hooper DC. 2003. Differential expression of growth factors at the cellular level in virus-infected brain. Proc. Natl. Acad. Sci. U. S. A. 100:6765-6770.
27. Tan GS, Preuss MA, Williams JC, Schnell MJ. 2007. The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcription. Proc. Natl. Acad. Sci. U. S. A. 104:7229-7234.
28. Moore SM, Hanlon CA. 2010. Rabies-specific antibodies: measuring surrogates of protection against a fatal disease. PLoS Negl. Trop. Dis. 4:e595. doi:10.1371/journal.pntd.0000595.
29. Plotkin SA. 2008. Vaccines: correlates of vaccine-induced immunity. Clin. Infect. Dis. 47:401-409.
30. Anonymous. 1997. WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. World Health Organization, Geneva, Switzerland.
31. Gobet R, Cerny A, Ruedi E, Hengartner H, Zinkernagel RM. 1988. The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus. Exp. Cell Biol. 56:175-180.
32. Ochsenbein AF, Zinkernagel RM. 2000. Natural antibodies and complement link innate and acquired immunity. Immunol. Today 21:624-630.
33. Klimovich VB. 2011. IgM and its receptors: structural and functional aspects. Biochemistry 76:534-549.
34. Flamand A, Raux H, Gaudin Y, Ruigrok RW. 1993. Mechanisms of rabies virus neutralization. Virology 194:302-313.